[Long term effects of raloxifen on the bones].
A set of now-completed, randomised clinical trials form the basis of our clinical understanding of the effects of raloxifen on the bones and are discussed in the paper.
Eiken
Pia A
PA
Nordsjaellands Hospital Hillerød, Endokrinologisk Klinik E0652, Hillerød. piei@noh.regionh.dk
D019386:Alendronate / Q000008:administration & dosage; D015519:Bone Density / Q000187:drug effects*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D005598:Fractures, Spontaneous / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy*; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage*; D012307:Risk Factors; D019379:Teriparatide / Q000008:administration & dosage; D013997:Time Factors; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D019379:Teriparatide; D020849:Raloxifene Hydrochloride; D019386:Alendronate